Does CBD Have Any Antiseptic Properties?

The relationship between infection and conventional prescription antibiotics

Could CBD work in the battle versus resistant bacterial pressures? The arise from the University of Queensland in Australia recommend that it is possible. However before examining the study in depth, it is useful to comprehend the evolution of the relationship between bacteria and prescription antibiotics.

Since the innovative discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have actually been an important tool in the battle versus bacteria and infections. And although we still use the same proven methods today, bacteria have actually progressed. When exposed to prescription antibiotics, certain bacteria, fungi and parasites are able to adapt and cancel the effectiveness of the drug by developing resistance.

It’s worth explaining that antimicrobial resistance was most likely to take place anyhow, as the genetic code for bacteria modifications over time. However, it is thought that the overuse of prescription antibiotics is an essential element that speeds up the advancement of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is an increasingly severe danger to global public health that requires action in all sectors of federal government and in society.” This has led researchers to think outside package by attempting to determine substances that could be helpful in the battle versus hazardous bacteria. Among these substances is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Scientists are trying to find new methods to assault infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive bacteria. Pressures of Gram-positive bacteria consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich provided his findings at an annual conference of the American Society for Microbiology. In vitro samples of both types of gram-positive bacteria were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD operates at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive pressures of resistant bacteria, which many traditional prescription antibiotics are beginning to stop working.

” In particular, the activity was picked versus the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active versus MRSA biofilms. “

The team also carried out another study using topical CBD to deal with a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to eliminate the infection, but just to decrease the number of bacterial cells.

Could CBD become an antibiotic?

While it is simple to hail this work as a substantial breakthrough in the antibacterial capabilities of CBD, it is prematurely to give up on penicillin.

Although it is thought that the effectiveness of CBD could originate from the way it attacks the biofilm surrounding bacterial cells, the authors are still unsure of the system of action of CBD. They also did not hesitate to point out the shortcomings of the study. Dr. Blaskovich pointed out that given that the outcomes remain in the initial phases, it is far too early for individuals to start treating their CBD infections themselves.

The study was also carried out in vitro (outside the human body), and there is a threat that the outcomes of medical trials will not be the same. Several substances have actually revealed antibacterial effectiveness in petri meals, but then failed at this important stage. It ought to also be pointed out that the two research studies were carried out in partnership with Botanix Pharmaceuticals Ltd, a pharmaceutical business specializing in topical CBD products.

However, this research study could be an essential step forward for CBD and the battle versus antimicrobial resistance. CBD continues to have a good security profile and is ruled out poisonous even in big amounts. Thankfully, Dr. Blaskovich and his team strategy to continue their research study. If you would like to read more on the subject I would advise reading both Spectral CBD and CBD Topia.

Scroll to top